NMNAT expression and its relation to NAD metabolism

Area of Science:

• Biochemistry
• Molecular Biology
• Enzymology

Background:

• Nicotinamide mononucleotide adenylyltransferase (NMNAT) is a crucial, rate-limiting enzyme in NAD biosynthesis.
• NAD (nicotinamide adenine dinucleotide) and NADP are vital coenzymes in anabolic and catabolic reactions, essential for cell survival under oxidative stress and DNA damage.
• Three isoforms of NMNAT exist, localized in the nucleus (NMNAT-1), cytoplasm (NMNAT-2), and mitochondria (NMNAT-3), each with distinct quaternary structures.

Purpose of the Study:

• To elucidate the multifaceted roles of NMNAT in cellular processes and disease.
• To explore the potential of NMNAT as a therapeutic target for various diseases, including cancer and neurodegenerative disorders.
• To highlight the enzyme's involvement in the activation of NAD analogs and its protective functions.

Main Methods:

• Enzyme kinetics and characterization of NMNAT activity.
• Analysis of NMNAT localization and isoform-specific functions.
• Investigation of NMNAT's role in drug metabolism and cellular protection mechanisms.

Main Results:

• NMNAT catalyzes the NAD biosynthesis pathway and activates antitumor prodrugs.
• NMNAT isoforms exhibit distinct subcellular localizations and functions.
• NMNAT demonstrates neuroprotective properties and correlates with DNA synthesis.

Conclusions:

• NMNAT plays a critical role in cellular metabolism, DNA integrity, and neuroprotection.
• The enzyme's lower activity in tumor cells presents a therapeutic vulnerability for cancer treatment.
• Targeting NAD synthesis pathways, involving NMNAT, offers promising strategies for chemoprevention and therapy of diseases like cancer, multiple sclerosis, and neurodegeneration.